SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
New stock news | Zerjung Pharmaceutical (688266.SH) submits application to Hong Kong Stock Exchange
New Stock News | Global Horticulture Delivers Prospectus to Hong Kong Stock Exchange
New Stock News | Huada Beidou Submits Application to Hong Kong Stock Exchange
New stock news | Zerjung Pharmaceutical (688266.SH) submits application to Hong Kong Stock Exchange
New Stock News | Global Horticulture Delivers Prospectus to Hong Kong Stock Exchange
New Stock News | Huada Beidou Submits Application to Hong Kong Stock Exchange
